Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
Low |
The actual benefit of BRONCHITOL is low.
|
Clinical Added Value
no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis.
|
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
dY7rPjgNkCkf7ngd